CN Patent

CN103804306A — 一类治疗糖尿病的化合物及其用途

Assigned to Individual · Expires 2014-05-21 · 12y expired

What this patent protects

本发明公开了一类化合物及其药物组合物和新用途，该类化合物可非常有效地治疗糖尿病，该类化合物的新用途为治疗糖尿病的药物中的用途，包括1型糖尿病和2型糖尿病、续发型糖尿病和妊娠期糖尿病。实施例实验证明上述化合物明显改善了糖尿病的症状,治疗糖尿病的作用效果非常显著。

USPTO Abstract

本发明公开了一类化合物及其药物组合物和新用途，该类化合物可非常有效地治疗糖尿病，该类化合物的新用途为治疗糖尿病的药物中的用途，包括1型糖尿病和2型糖尿病、续发型糖尿病和妊娠期糖尿病。实施例实验证明上述化合物明显改善了糖尿病的症状,治疗糖尿病的作用效果非常显著。

Drugs covered by this patent

cabozantinib-s-malate (CABOZANTINIB S-MALATE)

Patent Metadata

Patent number: CN103804306A
Jurisdiction: CN
Classification: —
Expires: 2014-05-21
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.